Publication | Open Access
Epigenetic upregulation of Schlafen11 renders 
WNT- and SHH-activated medulloblastomas sensitive to cisplatin
18
Citations
37
References
2022
Year
High SLFN11 expression is one factor which renders favorable outcomes in WNT-activated and a subset of SHH-activated medulloblastoma possibly through enhancing response to cisplatin.
| Year | Citations | |
|---|---|---|
Page 1
Page 1